Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × lazertinib × 30 days × Clear all

Phase

Phase 2 2 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Specimen Handling 86 Biopsy 66 Magnetic Resonance Spectroscopy 60 pembrolizumab 56 Cyclophosphamide 45 Nivolumab 34 fludarabine 27 venetoclax 26 Cetuximab 22 Carboplatin 20 Radiotherapy 19 Gemcitabine 19 Fluorouracil 19 Cisplatin 19 Bevacizumab 18 Ipilimumab 16 Cytarabine 16 Paclitaxel 15 Oxaliplatin 15 Azacitidine 15 Leucovorin 14 fludarabine phosphate 13 atezolizumab 13 X-Rays 13 Radiosurgery 13 tislelizumab 12 Temozolomide 12 Lenalidomide 12 Pemetrexed 11 Doxorubicin 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04077463 2026-03-17

Chrysalis-2

Janssen Research & Development, LLC

Phase 1 Active not recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡